Nature Meets Nasdaq

Med-X Gearing Up For a Possible NASDAQ Listing (Ticker: MXRX) But the Real Opportunity is Now – Before They Hit the Big Stage In certain use cases, their all-natural pesticides have outperformed chemical brands in independent lab tests, providing safer solutions without sacrificing results. The global biopesticide market is expected to grow ~3X by 2030, from $5.8 billion in 2022 to an impressive $17.6 billion by 20301. Med-X expects pesticide bans and other regulatory actions around the world to fuel their vision of Nature-Cide as the world's leading "clean" pest control product. Its plant-based formulation not only prioritizes safety, but delivers industrial-grade results, challenging long-held assumptions about what natural products can achieve in professional settings. NASDAQ Ticker: MXRX Reserved! The Real Opportunity to Become a Shareholder is Now! Med-X has earned national and international recognition for providing effective alternatives to conventional pesticides across residential, commercial, and the agricultural sectors. Proudly produced in the USA under strict quality standards, Nature-Cide reflects their commitment to sustainable pest management innovation. Med-X products are already available through e-commerce giants like Walmart, Amazon, and Kroger, and they plan to expand internationally. With $6.4M in sales in just four years, expanding to 41 international markets, Med-X is getting ready for the next step... Simpler, Safer, More Effective Pesticides Become A Med-X Shareholder At $4 Per Share Before Their NASDAQ Plans Unfold Disclosures This is a paid advertisement for Med-X's Regulation A+ Offering. Please read the offering circular at invest.medx-rx.com 1. Vantage Market Research - www.vantagemarketresearch.com/industry-report/biopesticides-market-1854

Disclaimer: This is a paid advertisement for educational purposes only and does not constitute financial advice. Investing involves risk and may not be suitable for all individuals. Past performance does not guarantee future results. Trading Cheat Sheet is owned and operated by PROTRADING RESEARCH LLC. We are not licensed financial advisors. Always consult with a certified financial professional before making investment decisions. IMPORTANT NOTICE AND DISCLAIMER Pro Trading Research, LLC ("PTR"), the owner of this website (the "Website"), cannot guarantee the accuracy or completeness of the information contained in any article, email, newsletter, or other publication posted on or viewed in connection with this website (the "Publications"). The author or authors of those Publications are solely responsible for their contents. PTR has not done any research or due diligence into the markets, industries, or companies which may appear or be mentioned in the Publications. PTR will NOT be liable for any loss or damage caused by a reader's reliance on information posted on the Website or contained in the Publications. FOR EDUCATIONAL AND INFORMATIONAL PURPOSES ONLY; NOT INVESTMENT ADVICE. This Website and the Publications are for educational and informational purposes only. This Website and the Publications do not purport to be a complete analysis of any company's financial position. This Website, the Publications or any statements made in the Publications are not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular individual. This Website or the statements made in the Publications should NOT be relied upon for purposes of transacting in any securities posted on the Website or mentioned in the Publications, nor should they be construed as a personalized recommendation to you to buy, sell, or hold any position in any security posted on this Website or mentioned in any Publications.b> SUBSTANTIAL RISK IN INVESTMENT. Any individual who chooses to invest in any securities including those mentioned in the Publications should do so with caution. Investing or transacting in securities involves substantial risk; you may lose some, all, or possibly more than your original investment. Readers bear responsibility for their own investment research and decisions and should review all investment decisions with a licensed or registered investment professional. NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER Neither PTR nor any of its respective owners or employees are registered or licensed as a securities broker-dealer, broker, an investment advisor, or an investment advisor representative with the U.S. Securities and Exchange Commission (SEC), any state securities regulatory authority, or any self-regulatory organization. Policies and contact:  Disclaimer  |  Privacy  |  Terms Trading Cheat Sheet 203 N La Salle Street, Suite 2100 | Chicago, IL 60601 unsubscribe